Monday, March 10, 2025

< + > DEA role must be clearly defined in controlled substance Rx via telemedicine, expert cautions

If the DEA's role is not properly limited, there could be an overreach where the agency influences or even dictates how healthcare practitioners make decisions, which could impact patient care, says Dan Cohen, president of RTM company Adhere+.

No comments:

Post a Comment

< + > Weekly Roundup – December 27, 2025

Welcome to our Healthcare IT Today Weekly Roundup . Each week, we’ll be providing a look back at the articles we posted and why they’re impo...